Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer

Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer

obr

2 months
49 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute offers his insight on the combination of ipilimumab + nivolumab in histologies of bladder cancer.
Up Next Autoplay